Previous 10 | Next 10 |
Incannex announces positive results from phase 2 clinical trial investigating the effect of IHL-42X for treatment of obstructive sleep apnoea PR Newswire Highlights: IHL-42X reduced primary endpoint apnoea hypopnea index relative to baseline at all three doses ...
Incannex Announces Positive Pre-IND Meeting with U.S. FDA for IHL-42X for Obstructive Sleep Apnoea PR Newswire MELBOURNE, Australia , May 17, 2022 /PRNewswire/ -- Incannex Healthcare Limited (NASDAQ: IXHL) (ASX: IHL), ('Incannex' or the 'Company') a clini...
Incannex Completes Share Sale and Purchase Agreement to Wholly Acquire APIRx Pharmaceuticals USA, LLC PR Newswire MELBOURNE, Australia , May 12, 2022 /PRNewswire/ -- Incannex Healthcare Limited (Nasdaq: IXHL) (ASX: IHL), ('Incannex' or the 'Company') a cl...
Incannex announces IHL-216A observed to have a neuroprotective effect in a rodent model of sports concussion; rapidly restores spatial memory post-concussion PR Newswire Highlights: The study compared IHL-216A to its component drugs, cannabidiol (CBD) and isofl...
Quarterly Activities Report and Appendix 4C Cash Flow Statement PR Newswire Highlights: Positive phase 2a clinical trial results for IHL-42X with 60% of trial participants experiencing at least a 55% reduction in the Apnoea Hypopnea Index ('AHI') 20% of IHL...
Incannex Completes Loyalty Option Program to Raise A$23.6M; Current Cash at Bank is Approximately A$40.0M PR Newswire MELBOURNE, Australia , April 28, 2022 /PRNewswire/ -- Incannex Healthcare Limited (Nasdaq: IXHL) (ASX: IHL), ('Incannex' or the 'Company'...
Gainers: Enphase Energy (ENPH) +5%. eXp World Holdings (EXPI) +5%. Lucid Group (LCID) +5%. Anavex Life Sciences (AVXL) +5%. Wejo Group Limited (WEJO) +5%. Losers: Incannex Healthcare (IXHL) -14%. Sono Group (SEV) -12%. F5 (FFIV) -11%. Alph...
Incannex Healthcare (NASDAQ:IXHL), a clinical-stage pharmaceutical company focused on cannabinoid and psychedelic medicines, announced an agreement to acquire the U.S.-based biotech APIRx Pharmaceutical. The ADRs of Australia-based Incannex (IXHL) are trading ~8% higher in the pre-m...
Mercurity Fintech Holding (MFH) +65%. Fast Radius (FSRD) +21%. Nikola (NKLA) +18% after investor event. Femasys (FEMY) +13%. BiondVax Pharmaceuticals (BVXV) +13% on research pact to develop nanosized antibody therapies. Incannex Healthcare (IXHL) +12%. D-MARKET Elektronik&...
Incannex to Acquire APIRx Pharmaceuticals USA, LLC PR Newswire Highlights: APIRx has twenty-two (22) active clinical and pre-clinical research and development projects therapeutic candidates are targeted at treating pain, dementia, Parkinson's disease, rest...
News, Short Squeeze, Breakout and More Instantly...
Incannex Healthcare Limited Company Name:
IXHL Stock Symbol:
NASDAQ Market:
Incannex Healthcare Limited Website:
NEW YORK and MELBOURNE, Australia, May 30, 2024 (GLOBE NEWSWIRE) -- Incannex Healthcare Inc. (Nasdaq: IXHL), (‘Incannex’ or the ‘Company’), a pharmaceutical company developing unique medicinal cannabinoid pharmacotherapies and psychedelic medicine therapies is ple...
Incannex Healthcare Inc. (IXHL) is expected to report for Q3 2024
MELBOURNE, Australia and NEW YORK, May 07, 2024 (GLOBE NEWSWIRE) -- Incannex Healthcare Inc. (Nasdaq: IXHL), (Incannex or the Company), a leading cannabinoid and psychedelic medicine biotechnology company, is pleased to announce the successful completion of a pre-IND (Investig...